Karen Peacock - Dec 1, 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Karen Peacock
Stock symbol
IDXX
Transactions as of
Dec 1, 2025
Transactions value $
$0
Form type
4
Date filed
12/3/2025, 05:01 PM
Previous filing
Oct 20, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Peacock Karen Director ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for Karen Peacock 2025-12-03 0001786299

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Award $0 +101 $0.00 101 Dec 1, 2025 Common Stock 101 Direct F1, F2
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +231 $0.00 231 Dec 1, 2025 Common Stock 231 $727.97 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from the date of her election to the IDEXX Laboratories, Inc. Board of Directors on October 6, 2025 until the 2026 annual meeting of stockholders.
F2 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock and vest in one installment on May 7, 2026 or on the date of the 2026 annual meeting of stockholders, whichever event is earlier.
F3 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests in one installment on May 7, 2026 or on the date of the 2026 annual meeting of stockholders, whichever event is earlier.